Roger Frechette Email & Phone Number

Boston, MA, US

Greater Boston, Massachusetts, US

NEPAssociates (NEPA) provides advisory and fractional executive services to life science enterprises, specializing in strategic planning/business development, commercial market assessment, and R&D Operations.

US

US

Organizing events focused on educational topics to help entrepreneurs to succeed. Engaging with entrepreneurs, executives, investors and executives in life sciences to network and learn with ENET's traditional Tech audience in the interest of expanding the rate of Biotech/High tech convergence.A Boston Area institution since 1991, ENET holds 20 meetings.

US

New York, New York, US

New York, New York, US

NEPA Engagement, serving as virtual executive in business development and operations. Akelos in an innovative research-based BioPharmaceutical company founded to address the Opioid epidemic through safe alternatives for the treatment of pain - the Company is actively seeking investment to support its initial goals of developing non-opioid, non-addictive.

Cambridge, MA, US

Cambridge, MA, US

Concerto Biosciences rebuilds microbial communities in, on, and around us to heal our bodies and our planet. The company's platform, kChip, is the first-ever discovery engine to experimentally measure millions of microbial interactions and identify inter-species interaction networks that are responsible for community behavior and microbiome function. We.

Boston, MA, US

NEPA Engagement, various roles: asset valuation/stratification, advisory support for financing, virtual business development executive.

Wakefield, Massachusetts, US

NEPA engagement, serving as US-based business development consultant for the Pistoia Alliance. Contributed to development of symposia, conferences and webinars. Conducted industry outreach to prospective new members, establishing a growing US-based business pipeline, with multiple new members enrolled. Created a new Emerging Science & Technology Interest.

Partnered with Procela, a small group of highly successful life sciences executives and independent consultants.Procela’s experienced team of executives have a proven track record in successfully founding, scaling and commercializing life sciences companies in the US, Europe and Internationally. With offices in Boston, Brussels, California, Dublin, and.

Cambridge, England, GB

NEPA engagement - led the effort to expand CN Bio's business interests in the US, focusing especially on the Greater Boston Life Science Super-Cluster. Advised the CEO on strategy for in-licensing opportunities and represented the company's technology to the area's leading Pharma/Biotech companies. Identified early interest and champions within the.

Wrocław, Dolnośląskie, PL

NEPA engagement, serving as Apeiron's virtual 'boots on the ground' business development executive in the US for establishing visibility and identifying prospective business partners in the Pharmaceutical and Flavors and Fragrances industry sectors. Built awareness of the company's capabilities with high visibility presentations and by organizing topical.

Copenhagen S, DK

NEPA engagement, serving as Boston Area Ambassador - representing MVA and various Danish/Swedish industry, academic and government stakeholders seeking to work with MA-based life science companies and academic institutions. Assisted multiple individual companies with new business connections; organized and hosted delegations of MVA regional leadership to.

New England PharmAssociates (NEPA) provided a fully equipped biotech lab/office suite to enable NSIV's biotech incubator operation. NEPA Principals were Sustaining Sponsors and Entrepreneurs-in-Residence, providing on-demand advisory services to the NSIV and portfolio companies.North Shore InnoVentures (NSIV) operates a business incubator to nurture.

Founded New England PharmAssociates, LLC to provide advisory and operational services for Biota's newly acquired portfolio programs derived from MaxThera (Beverly, MA) and Prolysis (Oxford, UK). Operated a laboratory facility in Beverly, MA intended to gradually transition acquired assets into the Biota R&D portfolio.

Founded MaxThera with an exclusive license to the drug discovery portfolio from Genome Therapeutics Corporation. The goal: to develop new treatments for bacterial infections - especially for infections caused by bacteria that have become resistant to current drugs. Wrote grants (NIH NIAID and Project BioShield) to raise US $3 million in non-dilutive funds..

A sole-proprietorship consultancy in life sciences offering R&D strategy, drug discovery and project management advisory services.

Boston, MA, US

Project Director at this Boston-based pharmaceutical company focused on synthetically modified tetracyclines and antibiotic resistance. Leader of the multi-disciplinary internal R&D effort and alliance manager for the strategic partnership with GlaxoWellcome (Madrid, Spain) resulting in the identification of Omadacycline (formerly PTK-0796) and.

Head of chemistry; initiated chemistry operations at RiboGene. Project Leader for two antibacterial programs, responsible for internal R&D. Alliance manager for the strategic partnership with Dainippon Pharmaceuticals, of Osaka Japan.

Medicinal chemist on numerous project teams in inflammation, cardiovascular, reproductive health, anti-fungal and anti-bacterial therapeutic areas. Innovator in integrating principles and methods of combinatorial chemistry with traditional medicinal chemistry and computational methods. Corporate citizenship - served as Chair of Site Safety Committee.

Nih Postoctoral Fellowship, Organic Chemistry

Ph.D., Organic Chemistry

Ba, Chemistry

Education record